J9040 HCPCS Level II code: Injection, bleomycin sulfate, 15 units
J9040 is the HCPCS code for “Injection, bleomycin sulfate, 15 units” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J9040Injection, bleomycin sulfate, 15 units
Short description: Bleomycin sulfate injection
HCPCS · United States
Medicare details
The indicators CMS publishes with J9040 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Chemotherapy
- Added
- Jan 1, 1984
Where J9040 sits
- 1J codesDrugs administered other than orally
- 2Active code J9040Injection, bleomycin sulfate, 15 units
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J9040 mean?
J9040 is the HCPCS code for “Injection, bleomycin sulfate, 15 units” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J9040?
CMS lists J9040’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J9040
All J codesJ9034Injection, bendamustine hcl (bendeka), 1 mgJ9035Injection, bevacizumab, 10 mgJ9036Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mgJ9037Injection, belantamab mafodotin-blmf, 0.5 mgJ9038Injection, axatilimab-csfr, 0.1 mgJ9039Injection, blinatumomab, 1 microgramJ9041Injection, bortezomib, 0.1 mgJ9042Injection, brentuximab vedotin, 1 mgJ9043Injection, cabazitaxel, 1 mgJ9044Injection, bortezomib, not otherwise specified, 0.1 mgJ9045Injection, carboplatin, 50 mgJ9046Injection, bortezomib (dr. reddy's), not therapeutically equivalent to j9041, 0.1 mg